You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 8,846,072


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,846,072 protect, and when does it expire?

Patent 8,846,072 protects POSIMIR and is included in one NDA.

This patent has fifty-four patent family members in twenty-nine countries.

Summary for Patent: 8,846,072
Title:Controlled delivery system
Abstract: The present invention relates to novel anesthetic compositions containing a non-polymeric carrier material and an anesthetic, where the compositions are suitable for providing a sustained local anesthesia without an initial burst and having a duration for about 24 hours or longer. Certain compositions are also provided that include a first anesthetic and a second anesthetic. In such compositions, the second anesthetic is a solvent for the first anesthetic and provides an initial anesthetic effect upon administration to a subject. The non-polymeric carrier may optionally be a high viscosity liquid carrier material such as a suitable sugar ester. The compositions can further include one or more additional ingredients including active and inactive materials. Methods of using the compositions of the invention to produce a sustained anesthetic effect at a site in a subject are also provided.
Inventor(s): Verity; A. Neil (Sunnyvale, CA)
Assignee: Durect Corporation (Cupertino, CA)
Application Number:13/789,416
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,846,072: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article delves into the details of United States Patent 8,846,072, titled "Controlled Delivery System," to provide a thorough analysis of its claims, scope, and implications.

Overview of the Patent

Publication Details

United States Patent 8,846,072 (US8846072B2) was published and granted for a "Controlled Delivery System" involving novel anesthetic compositions. The patent was filed on March 25, 2013, and granted on October 7, 2014[4].

Claims Analysis

Independent and Dependent Claims

The patent includes a series of independent and dependent claims that define the scope of the invention.

Independent Claims

  • The independent claims outline the core aspects of the invention, such as the composition of the anesthetic delivery system. For example, Claim 1 describes a composition comprising a non-polymeric carrier material and an anesthetic, where the carrier material has a high viscosity and does not crystallize under physiological conditions[4].

Dependent Claims

  • Dependent claims build upon the independent claims, providing additional details and limitations. These claims may specify the form of the composition (e.g., emulsion, paste, gel), the presence of additional anesthetic agents, or the viscosity range of the carrier material[4].

Claim Scope and Concepts

Scope Concepts

  • The claims can be categorized by scope concepts, which help in understanding the broader protection offered by the patent. For instance, the scope concepts might include the type of carrier material, the form of the composition, and the specific anesthetics used. This categorization is essential for analyzing the patent landscape and identifying gaps or opportunities in intellectual property protection[3].

Claim Charts and Coverage

  • Using tools like Claim Charts, which are part of patent analytics software, one can visually review the patent coverage. These charts help in determining whether a particular scope concept is applicable to a target product or method, making it easier to spot areas where claim coverage is lacking[3].

Patent Landscape

Related Patents and Applications

  • The patent landscape includes other patents and applications related to anesthetic delivery systems. Analyzing these related patents through tools like the Global Dossier or Common Citation Document (CCD) can provide insights into prior art and the citation data from various IP offices. This helps in understanding the global patent family and any potential overlaps or gaps in protection[1].

Competitor Analysis

  • Conducting a competitor analysis involves identifying other companies or inventors working on similar technologies. This can be done by searching patent databases and analyzing the claims and scope of competing patents. Such analysis is crucial for strategic decision-making and ensuring that the patent in question does not infringe on existing patents[3].

Inventorship and Ownership

Determining True Inventors

  • The proper determination of inventorship is critical for the validity of the patent. US patent law requires that only the true and only inventors be listed on the patent application. Failure to do so can result in the patent being declared invalid. The process involves identifying who conceived the idea and who reduced it to practice[2].

Assignment and Ownership Changes

  • Changes in ownership, such as patent assignments, must be carefully documented and searched through databases like the Patent Assignment Search website. This ensures that the current owner of the patent is correctly identified and that any legal actions or licensing agreements are valid[1].

Legal and Regulatory Considerations

Small Claims Patent Court

  • The concept of a small claims patent court has been explored to address the high costs and complexities associated with patent litigation. Studies by the Administrative Conference of the United States (ACUS) have considered the feasibility and structure of such a court, which could impact how disputes related to this patent are handled[5].

Public Search Facilities and Resources

  • Utilizing public search facilities like the USPTO Public Search Facility or Patent and Trademark Resource Centers (PTRCs) can provide valuable resources for searching and analyzing patents. These facilities offer trained staff and various search tools to help navigate the patent landscape effectively[1].

Practical Applications and Future Directions

Design Opportunities

  • The claims and scope of the patent can guide future design opportunities. By analyzing the scope concepts and claim coverage, engineers, scientists, and management can identify areas for innovation and ensure that new products or methods do not infringe on existing patents[3].

Market Impact

  • Understanding the patent landscape and the specific claims of US8846072B2 can help in assessing market impact. This includes identifying potential competitors, understanding the competitive advantage provided by the patent, and making informed decisions about licensing or litigation.

Key Takeaways

  • Claims Analysis: The patent includes independent and dependent claims that define the core aspects of the controlled delivery system.
  • Scope Concepts: Categorizing claims by scope concepts helps in understanding the broader protection and identifying gaps.
  • Patent Landscape: Analyzing related patents and applications is crucial for understanding prior art and global patent families.
  • Inventorship and Ownership: Correctly determining inventorship and documenting ownership changes are vital for patent validity.
  • Legal Considerations: The potential for a small claims patent court and the use of public search facilities are important legal and regulatory considerations.

FAQs

What is the main subject matter of United States Patent 8,846,072?

The main subject matter is a controlled delivery system involving novel anesthetic compositions with a non-polymeric carrier material.

How can one analyze the claims of this patent?

Using tools like Claim Charts and categorizing claims by scope concepts helps in understanding the claim coverage and identifying gaps.

Why is determining true inventors important for this patent?

Determining true inventors is crucial because failure to list the correct inventors can result in the patent being declared invalid.

What resources are available for searching and analyzing patents?

Resources include the USPTO Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and online databases like the Global Dossier.

How might the concept of a small claims patent court impact this patent?

A small claims patent court could simplify and reduce the costs associated with patent litigation, potentially affecting how disputes related to this patent are handled.

Sources

  1. USPTO: Search for patents - USPTO.
  2. Oregon State University: Determining Inventorship for US Patent Applications.
  3. Schwegman Lundberg & Woessner: Patent Analytics | Intellectual Property Law.
  4. Google Patents: US8846072B2 - Controlled delivery system.
  5. Administrative Conference of the United States: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,846,072

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Innocoll POSIMIR bupivacaine SOLUTION;INFILTRATION 204803-001 Feb 1, 2021 RX Yes Yes 8,846,072 ⤷  Subscribe Y METHOD FOR PROVIDING SUSTAINED LOCAL ANESTHESIA FOR AT LEAST 24 HOURS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,846,072

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E537844 ⤷  Subscribe
Australia 2005287175 ⤷  Subscribe
Brazil PI0515372 ⤷  Subscribe
Canada 2581287 ⤷  Subscribe
China 101035562 ⤷  Subscribe
Cyprus 1112625 ⤷  Subscribe
Cyprus 1116531 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.